Account
Inquiry
Tirzepatide (LY3298176) represents a breakthrough in metabolic research as the first dual GLP-1 and GIP receptor agonist peptide. This innovative compound has shown significant potential in clinical studies for weight management and glycemic control applications.
Our pharmaceutical-grade tirzepatide for sale is manufactured under strict GMP conditions, ensuring the highest standards of purity and consistency for research applications. The product undergoes rigorous quality control testing including HPLC, MS, and AAA analysis to verify identity and purity.
As a leading supplier of tirzepatide for sale, we offer flexible packaging options and customizable specifications to meet diverse research requirements. Our production facilities utilize advanced peptide synthesis technology to deliver consistent, high-quality material batch after batch.
The compound's unique mechanism of action simultaneously targets both GLP-1 and GIP receptors, making it particularly valuable for metabolic disorder research. This dual agonist approach may offer advantages over single-pathway therapies in certain applications.
Please note: This product is intended for research purposes only and not for human consumption. All orders must be for legitimate research applications in accordance with applicable laws and regulations.
